ClinicalTrials.Veeva

Menu

Effects of HIIT in Tolerance to Exercise of Individuals With HF and Coexisting COPD

U

Universidade Federal de Pernambuco

Status

Suspended

Conditions

Chronic Obstructive Pulmonary Disease
Heart Failure

Treatments

Other: Continuous aerobic training
Other: High-intensity interval training

Study type

Interventional

Funder types

Other

Identifiers

NCT04350541
07640919.4.0000.5208

Details and patient eligibility

About

INTRODUCTION: The complexity of the pathophysiology of heterogeneous diseases such as heart failure and obstructive pulmonary disease causes a different approach to these diseases or with a view as much as a better understanding of the same situations, with which the clinical profile of patients who are associated with an association is. It is known that regular physical training promotes progressive improvements in exercise tolerance, in the pulmonary ventilation / perfusion ratio and in respiratory function by strengthening. OBJECTIVE: To compare the effects of high-intensity interval training and continuous aerobic exercise, with peripheral endothelial function, brain natriuretic peptide levels, maximum exercise tolerance, distribution of lung volumes and quality of life of patients with obstructive pulmonary disease associated with heart failure. METHODS: This is a clinical, controlled, randomized and blinded trial. Peripheral endothelial function, tolerance to maximum and submaximal exercise, distribution of lung volumes, quality of life, presence of symptoms of depression and perception of clinical change will be evaluated. EXPECTED RESULTS: Incorporate into the care of these patients, new effective therapeutic approaches, of low cost and with greater technical and scientific evidence.

Enrollment

40 estimated patients

Sex

All

Ages

50 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Sedentary individuals with Heart Failure of all etiologies;
  • Diagnosed moderate and severe chronic obstructive pulmonary disease;
  • Clinical stability;
  • No change in the medication class within three months before the beginning of the research.

Exclusion criteria

  • Unstable angina;
  • Myocardial infarction;
  • Previous cardiac surgery up to three months before the beginning of the study;
  • Hemodynamic instability;
  • Orthopedic and neurological diseases;
  • Psychological and/or mental impairment.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

Interval training
Experimental group
Description:
Interval training will consist of 10 minutes of warm-up between 40-50% of the peak oxygen consumption (VO2peak), followed by four to six repetitions of three-minute intervals between 80-90% of VO2peak and three minutes between 40-50% VO2peak and finally, five minutes of cooling down between 30-40% of VO2peak.
Treatment:
Other: High-intensity interval training
Continuous training
Active Comparator group
Description:
The continuous aerobic training will consist of 10 minutes of warm-up with intensity between 40 and 50% of VO2peak, 20 minutes of conditioning between 60 and 70% of VO2peak and 5 minutes of cooling down between 30 and 40% of VO2peak.
Treatment:
Other: Continuous aerobic training

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems